Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 23 | 2023 | 849 | 4.040 |
Why?
|
Pericytes | 8 | 2022 | 81 | 2.450 |
Why?
|
Bronchoalveolar Lavage Fluid | 16 | 2022 | 117 | 2.320 |
Why?
|
Pulmonary Fibrosis | 7 | 2022 | 157 | 2.140 |
Why?
|
HIV Infections | 7 | 2021 | 791 | 1.660 |
Why?
|
Acute Lung Injury | 5 | 2022 | 35 | 1.650 |
Why?
|
Pulmonary Medicine | 6 | 2019 | 31 | 1.640 |
Why?
|
Extracellular Matrix Proteins | 2 | 2023 | 144 | 1.570 |
Why?
|
Critical Care | 7 | 2019 | 263 | 1.540 |
Why?
|
Fibronectins | 9 | 2012 | 130 | 1.490 |
Why?
|
Membrane Glycoproteins | 5 | 2014 | 370 | 1.410 |
Why?
|
Lung Injury | 5 | 2022 | 38 | 1.410 |
Why?
|
Integrins | 15 | 2009 | 115 | 1.360 |
Why?
|
Integrin alpha Chains | 5 | 2018 | 9 | 1.270 |
Why?
|
Myofibroblasts | 4 | 2019 | 60 | 1.240 |
Why?
|
Pneumonia, Ventilator-Associated | 3 | 2013 | 31 | 1.220 |
Why?
|
Mice | 26 | 2023 | 8474 | 1.080 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2012 | 36 | 1.080 |
Why?
|
Proteome | 3 | 2013 | 87 | 0.910 |
Why?
|
Endothelial Cells | 2 | 2020 | 384 | 0.910 |
Why?
|
Receptors, Immunologic | 3 | 2012 | 72 | 0.900 |
Why?
|
Cell Adhesion | 8 | 2012 | 324 | 0.880 |
Why?
|
Animals | 40 | 2023 | 20881 | 0.830 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 3 | 2018 | 20 | 0.820 |
Why?
|
Pulmonary Emphysema | 3 | 2017 | 71 | 0.810 |
Why?
|
HIV | 4 | 2017 | 56 | 0.810 |
Why?
|
Receptors, Cell Surface | 3 | 2014 | 248 | 0.810 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2021 | 123 | 0.790 |
Why?
|
Lymphocytes | 3 | 2012 | 228 | 0.780 |
Why?
|
Proteomics | 3 | 2014 | 246 | 0.770 |
Why?
|
Biomarkers | 4 | 2017 | 1593 | 0.740 |
Why?
|
Academic Medical Centers | 2 | 2019 | 281 | 0.700 |
Why?
|
Somatomedins | 2 | 2012 | 16 | 0.680 |
Why?
|
Financial Management | 1 | 2019 | 10 | 0.680 |
Why?
|
Membrane Proteins | 1 | 2023 | 617 | 0.630 |
Why?
|
Trypsin Inhibitors | 1 | 2017 | 15 | 0.610 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2018 | 66 | 0.600 |
Why?
|
Fibroblasts | 7 | 2018 | 902 | 0.590 |
Why?
|
alpha 1-Antitrypsin | 1 | 2017 | 61 | 0.590 |
Why?
|
Diphtheria Toxin | 1 | 2017 | 18 | 0.570 |
Why?
|
Suction | 1 | 2017 | 33 | 0.570 |
Why?
|
HIV-1 | 2 | 2013 | 177 | 0.560 |
Why?
|
Macrophages | 1 | 2020 | 647 | 0.560 |
Why?
|
Mice, Inbred C57BL | 11 | 2022 | 2791 | 0.560 |
Why?
|
Mouth | 1 | 2017 | 64 | 0.560 |
Why?
|
Pharynx | 1 | 2017 | 89 | 0.540 |
Why?
|
Bleomycin | 4 | 2022 | 67 | 0.510 |
Why?
|
Humans | 48 | 2022 | 68618 | 0.500 |
Why?
|
Hyperoxia | 2 | 2012 | 27 | 0.490 |
Why?
|
Skin Physiological Phenomena | 1 | 2014 | 13 | 0.470 |
Why?
|
Transforming Growth Factor beta | 4 | 2018 | 384 | 0.460 |
Why?
|
Sepsis | 2 | 2018 | 233 | 0.450 |
Why?
|
Macrophages, Alveolar | 3 | 2020 | 34 | 0.440 |
Why?
|
Inflammation | 6 | 2022 | 1030 | 0.440 |
Why?
|
Leadership | 3 | 2019 | 136 | 0.440 |
Why?
|
Receptor, IGF Type 1 | 2 | 2013 | 42 | 0.430 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 110 | 0.430 |
Why?
|
Cell Movement | 5 | 2009 | 630 | 0.430 |
Why?
|
Mentors | 1 | 2013 | 81 | 0.420 |
Why?
|
Up-Regulation | 7 | 2018 | 682 | 0.410 |
Why?
|
Wound Healing | 1 | 2014 | 260 | 0.400 |
Why?
|
Lymphocyte Activation | 3 | 2018 | 397 | 0.400 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2011 | 14 | 0.400 |
Why?
|
Cytokines | 6 | 2016 | 866 | 0.400 |
Why?
|
Collagen | 4 | 2023 | 636 | 0.390 |
Why?
|
Myeloid Cells | 1 | 2012 | 57 | 0.380 |
Why?
|
Cotinine | 1 | 2011 | 40 | 0.370 |
Why?
|
Skin | 1 | 2014 | 451 | 0.370 |
Why?
|
Disease Models, Animal | 6 | 2018 | 2550 | 0.370 |
Why?
|
Antibodies, Monoclonal | 3 | 2013 | 511 | 0.370 |
Why?
|
Cell Differentiation | 2 | 2013 | 1034 | 0.360 |
Why?
|
Intensive Care Units | 2 | 2022 | 344 | 0.360 |
Why?
|
Signal Transduction | 4 | 2013 | 2689 | 0.350 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 127 | 0.350 |
Why?
|
Mice, Knockout | 8 | 2022 | 1692 | 0.340 |
Why?
|
Fibrosis | 3 | 2019 | 371 | 0.340 |
Why?
|
Cell Line | 8 | 2021 | 1752 | 0.330 |
Why?
|
Sleep Medicine Specialty | 2 | 2018 | 2 | 0.320 |
Why?
|
Sarcoidosis, Pulmonary | 2 | 2020 | 17 | 0.320 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 226 | 0.320 |
Why?
|
Triggering Receptor Expressed on Myeloid Cells-1 | 3 | 2012 | 3 | 0.310 |
Why?
|
Faculty, Medical | 2 | 2019 | 110 | 0.310 |
Why?
|
Female | 19 | 2022 | 38074 | 0.310 |
Why?
|
Graft vs Host Disease | 2 | 2022 | 163 | 0.300 |
Why?
|
Adult | 16 | 2022 | 21403 | 0.300 |
Why?
|
Muscle, Smooth | 3 | 2003 | 117 | 0.300 |
Why?
|
Male | 22 | 2022 | 37321 | 0.300 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 1293 | 0.290 |
Why?
|
Radiation Pneumonitis | 1 | 2006 | 4 | 0.280 |
Why?
|
Protein Array Analysis | 1 | 2006 | 32 | 0.280 |
Why?
|
Biomedical Research | 2 | 2015 | 310 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 46 | 0.270 |
Why?
|
Middle Aged | 14 | 2018 | 21147 | 0.270 |
Why?
|
Oxidative Stress | 1 | 2009 | 718 | 0.260 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 1753 | 0.240 |
Why?
|
Genome | 1 | 2004 | 54 | 0.240 |
Why?
|
Mice, Transgenic | 3 | 2017 | 1033 | 0.240 |
Why?
|
Lymphocyte Subsets | 1 | 2004 | 16 | 0.240 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2000 | 317 | 0.230 |
Why?
|
T-Lymphocytes | 1 | 2008 | 597 | 0.230 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2005 | 223 | 0.230 |
Why?
|
MAP Kinase Signaling System | 1 | 2005 | 247 | 0.230 |
Why?
|
Smoking | 2 | 2016 | 1452 | 0.230 |
Why?
|
Virus Replication | 2 | 2020 | 104 | 0.220 |
Why?
|
Extracellular Matrix | 3 | 2018 | 493 | 0.220 |
Why?
|
Immunohistochemistry | 5 | 2008 | 1174 | 0.220 |
Why?
|
Cells, Cultured | 8 | 2018 | 2673 | 0.210 |
Why?
|
Thorax | 1 | 2022 | 49 | 0.210 |
Why?
|
Nanotubes, Carbon | 2 | 2020 | 73 | 0.210 |
Why?
|
Embryonic Development | 1 | 2023 | 100 | 0.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 245 | 0.210 |
Why?
|
Hydroxyproline | 1 | 2022 | 33 | 0.200 |
Why?
|
Physicians | 2 | 2022 | 324 | 0.200 |
Why?
|
Physician's Role | 1 | 2003 | 116 | 0.200 |
Why?
|
Endotoxins | 1 | 2022 | 76 | 0.200 |
Why?
|
Receptors, Virus | 2 | 2018 | 20 | 0.200 |
Why?
|
Tamoxifen | 1 | 2022 | 62 | 0.200 |
Why?
|
Burnout, Professional | 1 | 2022 | 64 | 0.200 |
Why?
|
Case-Control Studies | 3 | 2017 | 1553 | 0.200 |
Why?
|
Angiotensin II | 2 | 2001 | 220 | 0.190 |
Why?
|
Fellowships and Scholarships | 2 | 2015 | 127 | 0.190 |
Why?
|
Cell Proliferation | 3 | 2010 | 1174 | 0.190 |
Why?
|
Gene Expression | 3 | 2015 | 770 | 0.190 |
Why?
|
Virus Latency | 1 | 2020 | 10 | 0.190 |
Why?
|
Cell Adhesion Molecules | 2 | 2000 | 199 | 0.190 |
Why?
|
Granuloma | 1 | 2020 | 21 | 0.180 |
Why?
|
Simian Immunodeficiency Virus | 1 | 2020 | 28 | 0.180 |
Why?
|
Oligopeptides | 2 | 1998 | 152 | 0.180 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2020 | 31 | 0.180 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 48 | 0.180 |
Why?
|
Blotting, Western | 3 | 2008 | 954 | 0.180 |
Why?
|
Critical Illness | 2 | 2013 | 191 | 0.180 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2000 | 20 | 0.180 |
Why?
|
Societies, Medical | 1 | 2003 | 403 | 0.180 |
Why?
|
Biopolymers | 1 | 2000 | 21 | 0.180 |
Why?
|
Vitronectin | 2 | 2000 | 12 | 0.180 |
Why?
|
Escherichia coli | 1 | 2022 | 368 | 0.180 |
Why?
|
Young Adult | 3 | 2018 | 5717 | 0.170 |
Why?
|
Relative Value Scales | 1 | 2019 | 8 | 0.170 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 45 | 0.170 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 24 | 0.170 |
Why?
|
Stromal Cells | 2 | 2017 | 113 | 0.170 |
Why?
|
Salaries and Fringe Benefits | 1 | 2019 | 29 | 0.170 |
Why?
|
Reimbursement Mechanisms | 1 | 2019 | 37 | 0.170 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 25 | 0.170 |
Why?
|
Negotiating | 1 | 2019 | 18 | 0.170 |
Why?
|
Research Support as Topic | 1 | 2019 | 58 | 0.170 |
Why?
|
Efficiency | 1 | 2019 | 49 | 0.170 |
Why?
|
Organizational Innovation | 1 | 2019 | 55 | 0.170 |
Why?
|
Clinical Medicine | 1 | 2019 | 20 | 0.170 |
Why?
|
Personnel Management | 1 | 2018 | 11 | 0.160 |
Why?
|
Sexism | 1 | 2018 | 11 | 0.160 |
Why?
|
Epithelial Cells | 3 | 2014 | 431 | 0.160 |
Why?
|
Integrin alpha6beta4 | 1 | 2018 | 1 | 0.160 |
Why?
|
Virus Attachment | 1 | 2018 | 3 | 0.160 |
Why?
|
Integrin alpha6 | 1 | 2018 | 2 | 0.160 |
Why?
|
Adenoviruses, Human | 1 | 2018 | 12 | 0.160 |
Why?
|
Apoptosis | 4 | 2008 | 1641 | 0.160 |
Why?
|
Aged | 6 | 2018 | 14862 | 0.160 |
Why?
|
Laminin | 1 | 2018 | 62 | 0.160 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2018 | 4 | 0.160 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2017 | 1 | 0.150 |
Why?
|
Curriculum | 2 | 2015 | 575 | 0.150 |
Why?
|
Actins | 2 | 2013 | 249 | 0.150 |
Why?
|
X-Box Binding Protein 1 | 1 | 2018 | 16 | 0.150 |
Why?
|
Aorta | 2 | 2000 | 316 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2022 | 445 | 0.150 |
Why?
|
Graft vs Leukemia Effect | 1 | 2018 | 33 | 0.150 |
Why?
|
Muscle Contraction | 1 | 1998 | 210 | 0.150 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 106 | 0.150 |
Why?
|
Flow Cytometry | 2 | 2011 | 489 | 0.150 |
Why?
|
Emergency Medicine | 1 | 2018 | 88 | 0.150 |
Why?
|
Gene Deletion | 1 | 2018 | 235 | 0.150 |
Why?
|
MicroRNAs | 1 | 2022 | 447 | 0.140 |
Why?
|
Sarcoidosis | 1 | 2017 | 77 | 0.140 |
Why?
|
Capillary Permeability | 1 | 2017 | 69 | 0.140 |
Why?
|
Reference Values | 3 | 2014 | 579 | 0.140 |
Why?
|
Immune System | 1 | 2017 | 63 | 0.140 |
Why?
|
Ductus Arteriosus | 1 | 1996 | 13 | 0.140 |
Why?
|
Pediatrics | 1 | 2019 | 341 | 0.130 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 214 | 0.130 |
Why?
|
United States | 4 | 2022 | 7367 | 0.130 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 232 | 0.130 |
Why?
|
Bronchoscopy | 3 | 2016 | 147 | 0.130 |
Why?
|
Leukocytes | 1 | 2016 | 99 | 0.130 |
Why?
|
Models, Animal | 1 | 2017 | 252 | 0.130 |
Why?
|
Tenascin | 1 | 1995 | 39 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2006 | 507 | 0.130 |
Why?
|
Neutrophils | 2 | 2012 | 204 | 0.130 |
Why?
|
Ligands | 2 | 2008 | 317 | 0.130 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 498 | 0.130 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2015 | 2 | 0.130 |
Why?
|
Barotrauma | 1 | 1995 | 3 | 0.130 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2014 | 23 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2009 | 492 | 0.120 |
Why?
|
Asthma | 1 | 2019 | 345 | 0.120 |
Why?
|
CD4 Antigens | 1 | 2014 | 42 | 0.120 |
Why?
|
Jurkat Cells | 2 | 2008 | 59 | 0.120 |
Why?
|
Cohort Studies | 2 | 2017 | 2358 | 0.120 |
Why?
|
Inflammation Mediators | 2 | 2017 | 244 | 0.120 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 371 | 0.120 |
Why?
|
Career Choice | 1 | 2015 | 98 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 139 | 0.120 |
Why?
|
Aging | 2 | 1996 | 911 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 69 | 0.110 |
Why?
|
Rats | 7 | 2001 | 5300 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 94 | 0.110 |
Why?
|
Base Sequence | 3 | 2004 | 1015 | 0.110 |
Why?
|
Protein Interaction Maps | 1 | 2013 | 30 | 0.110 |
Why?
|
Breath Tests | 1 | 2012 | 23 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2013 | 62 | 0.110 |
Why?
|
Immunoassay | 1 | 2012 | 64 | 0.110 |
Why?
|
Biomechanical Phenomena | 1 | 2014 | 368 | 0.110 |
Why?
|
Monitoring, Physiologic | 2 | 2011 | 219 | 0.110 |
Why?
|
Mannose | 1 | 2012 | 9 | 0.110 |
Why?
|
Molecular Sequence Data | 3 | 2004 | 1447 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2013 | 219 | 0.100 |
Why?
|
In Vitro Techniques | 1 | 2013 | 765 | 0.100 |
Why?
|
Child | 2 | 2022 | 6405 | 0.100 |
Why?
|
Microscopy, Fluorescence | 2 | 2011 | 261 | 0.100 |
Why?
|
Prospective Studies | 4 | 2015 | 3705 | 0.100 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2012 | 48 | 0.100 |
Why?
|
Acetylglucosamine | 1 | 2012 | 46 | 0.100 |
Why?
|
Drug Carriers | 1 | 2012 | 90 | 0.100 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 56 | 0.100 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2002 | 11 | 0.100 |
Why?
|
Virion | 2 | 2002 | 31 | 0.100 |
Why?
|
Calcitonin | 1 | 2011 | 21 | 0.100 |
Why?
|
Chemokines | 1 | 2012 | 119 | 0.100 |
Why?
|
Kidney | 3 | 2004 | 945 | 0.100 |
Why?
|
Trans-Activators | 2 | 2021 | 237 | 0.090 |
Why?
|
HIV Seropositivity | 2 | 2006 | 66 | 0.090 |
Why?
|
Animals, Newborn | 3 | 2003 | 396 | 0.090 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2011 | 46 | 0.090 |
Why?
|
Chimera | 1 | 2010 | 33 | 0.090 |
Why?
|
Monocytes | 1 | 2012 | 210 | 0.090 |
Why?
|
Protein Precursors | 1 | 2011 | 105 | 0.090 |
Why?
|
Transfection | 3 | 2005 | 782 | 0.090 |
Why?
|
Thymus Gland | 1 | 2010 | 97 | 0.090 |
Why?
|
Oximetry | 1 | 1990 | 29 | 0.090 |
Why?
|
Allergens | 1 | 2010 | 54 | 0.090 |
Why?
|
RNA, Messenger | 3 | 2008 | 1664 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2011 | 117 | 0.090 |
Why?
|
Mesoderm | 2 | 2003 | 231 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2004 | 231 | 0.090 |
Why?
|
DNA, Complementary | 2 | 2004 | 251 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2011 | 180 | 0.090 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2009 | 7 | 0.090 |
Why?
|
Peroxiredoxins | 1 | 2009 | 34 | 0.090 |
Why?
|
Down-Regulation | 1 | 2011 | 447 | 0.090 |
Why?
|
Lymph Nodes | 2 | 2002 | 258 | 0.090 |
Why?
|
Neurons | 1 | 1995 | 881 | 0.090 |
Why?
|
rho-Associated Kinases | 1 | 2009 | 32 | 0.090 |
Why?
|
Receptors, Fibronectin | 3 | 2000 | 6 | 0.090 |
Why?
|
Receptors, Vitronectin | 3 | 2000 | 11 | 0.090 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2009 | 37 | 0.080 |
Why?
|
Ligation | 2 | 2018 | 83 | 0.080 |
Why?
|
Species Specificity | 1 | 2009 | 303 | 0.080 |
Why?
|
Morphogenesis | 1 | 2009 | 159 | 0.080 |
Why?
|
Survival Analysis | 1 | 2011 | 714 | 0.080 |
Why?
|
Intestines | 1 | 2009 | 114 | 0.080 |
Why?
|
Organizational Culture | 2 | 2019 | 59 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 60 | 0.080 |
Why?
|
Risk Assessment | 2 | 2014 | 2007 | 0.080 |
Why?
|
Collagen Type IV | 1 | 2008 | 28 | 0.080 |
Why?
|
Integrin beta Chains | 1 | 2008 | 7 | 0.080 |
Why?
|
Surveys and Questionnaires | 3 | 2022 | 2800 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 4 | 2001 | 2083 | 0.080 |
Why?
|
Retinoblastoma Protein | 1 | 2008 | 75 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 2279 | 0.070 |
Why?
|
Collagen Type I | 1 | 2008 | 175 | 0.070 |
Why?
|
Selectins | 2 | 2016 | 3 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2077 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2013 | 4848 | 0.070 |
Why?
|
Interprofessional Relations | 1 | 2008 | 188 | 0.070 |
Why?
|
Abnormalities, Radiation-Induced | 1 | 2006 | 4 | 0.070 |
Why?
|
Pneumonia | 1 | 2008 | 110 | 0.070 |
Why?
|
Washington | 1 | 2006 | 27 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2006 | 27 | 0.070 |
Why?
|
3T3 Cells | 2 | 2004 | 124 | 0.070 |
Why?
|
Prevalence | 1 | 2011 | 1619 | 0.070 |
Why?
|
Respiratory Mucosa | 1 | 2006 | 52 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2003 | 282 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 434 | 0.070 |
Why?
|
Tumor Cells, Cultured | 3 | 2000 | 852 | 0.070 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2004 | 126 | 0.070 |
Why?
|
Staurosporine | 1 | 2005 | 19 | 0.060 |
Why?
|
Chromones | 1 | 2005 | 33 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2008 | 331 | 0.060 |
Why?
|
Morpholines | 1 | 2005 | 79 | 0.060 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2004 | 10 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2005 | 132 | 0.060 |
Why?
|
Phosphorylation | 1 | 2008 | 1200 | 0.060 |
Why?
|
Adhesins, Bacterial | 1 | 2004 | 13 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2004 | 91 | 0.060 |
Why?
|
Bacterial Adhesion | 1 | 2004 | 33 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2004 | 52 | 0.060 |
Why?
|
Exons | 1 | 2004 | 122 | 0.060 |
Why?
|
Flavonoids | 1 | 2005 | 109 | 0.060 |
Why?
|
Protein Structure, Secondary | 1 | 2004 | 136 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 144 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2004 | 188 | 0.060 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 5 | 0.060 |
Why?
|
Gene Products, gag | 1 | 2004 | 11 | 0.060 |
Why?
|
HIV Antigens | 1 | 2004 | 9 | 0.060 |
Why?
|
Viral Matrix Proteins | 1 | 2004 | 10 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 337 | 0.060 |
Why?
|
Smad Proteins | 1 | 2004 | 25 | 0.060 |
Why?
|
Models, Genetic | 1 | 2004 | 161 | 0.060 |
Why?
|
Keratins | 1 | 2003 | 48 | 0.060 |
Why?
|
RNA, Viral | 1 | 2004 | 93 | 0.060 |
Why?
|
Genetic Variation | 1 | 2004 | 220 | 0.060 |
Why?
|
Pneumocystis | 2 | 1993 | 3 | 0.060 |
Why?
|
Protein Conformation | 1 | 2004 | 362 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 301 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2003 | 282 | 0.050 |
Why?
|
Medical Laboratory Science | 1 | 2003 | 8 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 1995 | 1083 | 0.050 |
Why?
|
Sex Factors | 2 | 2018 | 1266 | 0.050 |
Why?
|
Viral Proteins | 1 | 2004 | 150 | 0.050 |
Why?
|
Information Systems | 1 | 2003 | 45 | 0.050 |
Why?
|
Lipopolysaccharides | 2 | 2018 | 455 | 0.050 |
Why?
|
Models, Molecular | 1 | 2004 | 546 | 0.050 |
Why?
|
North America | 1 | 2022 | 112 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2004 | 245 | 0.050 |
Why?
|
Odds Ratio | 2 | 2014 | 880 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 26 | 0.050 |
Why?
|
Genotype | 1 | 2004 | 786 | 0.050 |
Why?
|
Certification | 1 | 2003 | 66 | 0.050 |
Why?
|
Sex Distribution | 1 | 2003 | 274 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2004 | 742 | 0.050 |
Why?
|
Cell Survival | 1 | 2005 | 901 | 0.050 |
Why?
|
Canada | 1 | 2003 | 267 | 0.050 |
Why?
|
Protein Binding | 1 | 2005 | 1027 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2008 | 3259 | 0.050 |
Why?
|
Age Distribution | 1 | 2003 | 320 | 0.050 |
Why?
|
DNA | 1 | 2004 | 597 | 0.050 |
Why?
|
Workload | 1 | 2003 | 103 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 659 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 615 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2004 | 627 | 0.050 |
Why?
|
Employment | 1 | 2003 | 154 | 0.050 |
Why?
|
Needs Assessment | 1 | 2003 | 186 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2004 | 597 | 0.050 |
Why?
|
Hypoxia | 1 | 2022 | 169 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2001 | 107 | 0.050 |
Why?
|
Logistic Models | 2 | 2014 | 1420 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 24 | 0.050 |
Why?
|
Thromboplastin | 1 | 2000 | 21 | 0.050 |
Why?
|
Carbon Tetrachloride | 1 | 2000 | 15 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2021 | 102 | 0.040 |
Why?
|
Heparitin Sulfate | 1 | 2000 | 20 | 0.040 |
Why?
|
HIV Long Terminal Repeat | 1 | 2000 | 8 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2000 | 62 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2000 | 165 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2000 | 58 | 0.040 |
Why?
|
Bile Ducts | 1 | 2000 | 59 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 700 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1851 | 0.040 |
Why?
|
Epitopes | 1 | 2000 | 146 | 0.040 |
Why?
|
Proteoglycans | 1 | 2000 | 103 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2003 | 442 | 0.040 |
Why?
|
Colorado | 1 | 2019 | 26 | 0.040 |
Why?
|
Genes, Wilms Tumor | 1 | 1999 | 5 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 447 | 0.040 |
Why?
|
Pyroptosis | 1 | 2018 | 8 | 0.040 |
Why?
|
Pandemics | 1 | 2022 | 352 | 0.040 |
Why?
|
Cecum | 1 | 2018 | 39 | 0.040 |
Why?
|
Phenylephrine | 1 | 1998 | 61 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2019 | 85 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2000 | 290 | 0.040 |
Why?
|
Mucoproteins | 1 | 1998 | 3 | 0.040 |
Why?
|
HT29 Cells | 1 | 2018 | 42 | 0.040 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1998 | 5 | 0.040 |
Why?
|
Cell Membrane | 1 | 2000 | 525 | 0.040 |
Why?
|
Surface Plasmon Resonance | 1 | 2018 | 50 | 0.040 |
Why?
|
Cricetulus | 1 | 2018 | 98 | 0.040 |
Why?
|
Serotonin | 1 | 1998 | 144 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1998 | 52 | 0.040 |
Why?
|
Synapses | 1 | 2000 | 222 | 0.040 |
Why?
|
CHO Cells | 1 | 2018 | 161 | 0.040 |
Why?
|
Endothelium | 1 | 1998 | 98 | 0.040 |
Why?
|
Immunoglobulins | 1 | 1998 | 97 | 0.040 |
Why?
|
Antibodies | 1 | 1998 | 241 | 0.040 |
Why?
|
Astrocytes | 1 | 2000 | 270 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2000 | 274 | 0.040 |
Why?
|
Heart | 1 | 2001 | 850 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2008 | 7029 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1996 | 74 | 0.030 |
Why?
|
Macaca mulatta | 1 | 1996 | 77 | 0.030 |
Why?
|
Tracheal Neoplasms | 1 | 1996 | 3 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2016 | 20 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 69 | 0.030 |
Why?
|
Bronchial Neoplasms | 1 | 1996 | 12 | 0.030 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 5 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2016 | 15 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 63 | 0.030 |
Why?
|
Angiopoietin-1 | 1 | 2016 | 12 | 0.030 |
Why?
|
Sarcoma, Kaposi | 1 | 1996 | 25 | 0.030 |
Why?
|
Immunity | 1 | 2016 | 67 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 248 | 0.030 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1993 | 85 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2018 | 329 | 0.030 |
Why?
|
Receptors, Antigen | 1 | 1995 | 6 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2016 | 123 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 94 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2017 | 562 | 0.030 |
Why?
|
Chromatography, Affinity | 1 | 1995 | 73 | 0.030 |
Why?
|
Myocardium | 1 | 2001 | 1204 | 0.030 |
Why?
|
RNA | 1 | 2016 | 171 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 1998 | 320 | 0.030 |
Why?
|
DNA Primers | 1 | 1995 | 302 | 0.030 |
Why?
|
Gestational Age | 1 | 1996 | 389 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 1995 | 176 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 1995 | 33 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1995 | 189 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 320 | 0.030 |
Why?
|
Graft Rejection | 1 | 1998 | 458 | 0.030 |
Why?
|
Research Design | 1 | 2019 | 729 | 0.030 |
Why?
|
Transcriptome | 1 | 2016 | 164 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1995 | 357 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2014 | 242 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 306 | 0.030 |
Why?
|
Chickens | 1 | 1995 | 232 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 1995 | 190 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 381 | 0.030 |
Why?
|
Pentamidine | 1 | 1993 | 7 | 0.030 |
Why?
|
Radiography | 1 | 2014 | 572 | 0.030 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1993 | 57 | 0.030 |
Why?
|
Sputum | 1 | 1993 | 51 | 0.030 |
Why?
|
Pleural Effusion | 1 | 1993 | 74 | 0.030 |
Why?
|
Agglutination | 1 | 2012 | 3 | 0.030 |
Why?
|
Models, Biological | 1 | 2017 | 981 | 0.030 |
Why?
|
Maleimides | 1 | 2012 | 15 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2012 | 8 | 0.030 |
Why?
|
Polymethacrylic Acids | 1 | 2012 | 19 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 79 | 0.030 |
Why?
|
Survival Rate | 1 | 1995 | 1056 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2012 | 187 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2014 | 1046 | 0.020 |
Why?
|
Hemoglobins, Abnormal | 1 | 1990 | 5 | 0.020 |
Why?
|
Lighting | 1 | 1990 | 9 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 1990 | 20 | 0.020 |
Why?
|
Coloring Agents | 1 | 1990 | 66 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 1426 | 0.020 |
Why?
|
History, 20th Century | 1 | 1990 | 248 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1864 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
Anemia | 1 | 1990 | 104 | 0.020 |
Why?
|
Prognosis | 1 | 2014 | 2093 | 0.020 |
Why?
|
Fetus | 1 | 2009 | 157 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 219 | 0.020 |
Why?
|
Risk Factors | 2 | 1995 | 5731 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 328 | 0.020 |
Why?
|
Treponema pallidum | 1 | 2004 | 5 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 17 | 0.010 |
Why?
|
Receptors, Angiotensin | 1 | 2001 | 59 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 272 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2001 | 80 | 0.010 |
Why?
|
Integrin alpha1beta1 | 1 | 2000 | 5 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2001 | 146 | 0.010 |
Why?
|
Osteopontin | 1 | 2000 | 28 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2000 | 45 | 0.010 |
Why?
|
Long-Term Potentiation | 1 | 2000 | 53 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 86 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 138 | 0.010 |
Why?
|
Indomethacin | 1 | 2000 | 107 | 0.010 |
Why?
|
Wilms Tumor | 1 | 1999 | 47 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2000 | 236 | 0.010 |
Why?
|
Memory | 1 | 2000 | 214 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1999 | 100 | 0.010 |
Why?
|
Learning | 1 | 2000 | 186 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 1047 | 0.010 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1999 | 52 | 0.010 |
Why?
|
Peptides | 1 | 2001 | 455 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2000 | 313 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 626 | 0.010 |
Why?
|
Hippocampus | 1 | 2000 | 471 | 0.010 |
Why?
|
Melanoma | 1 | 2000 | 335 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1996 | 98 | 0.010 |
Why?
|
Pneumocystis Infections | 1 | 1993 | 2 | 0.010 |
Why?
|
Aerosols | 1 | 1993 | 42 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1996 | 7277 | 0.010 |
Why?
|
Brain | 1 | 2000 | 2176 | 0.010 |
Why?
|